AARTI PHARMALABS LIMITED (AARTIPHARM)

NSE: ₹643.75
BSE: ₹643.65
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 356.14 373.03 414.82 393.49 377.29 470.95 529.62 375.31 417.29 425.25 579.70 534.59
YOY Revenue Growth % - - 10.83% 9.87% 5.94% 26.25% 27.68% -4.62% 10.6% -9.7% 9.46% 42.44%
Other Income 0.00 0.20 5.69 2.11 2.95 11.94 -2.51 1.60 3.15 -0.37 10.53 2.93
Total Income 356.14 373.23 420.50 395.60 380.24 482.88 527.12 376.91 420.44 424.88 590.23 537.52
Total Expenses + 302.48 305.79 329.22 332.37 316.81 386.70 413.62 309.73 378.74 363.51 507.65 441.30
Cost of Materials Consumed 196.88 191.11 179.69 191.41 196.38 242.91 173.29 192.85 204.45 209.85 227.38 254.84
Employee Benefit Expense 29.84 34.29 34.67 37.01 35.47 39.02 41.38 41.01 43.12 42.62 43.73 49.77
Other Expenses 61.73 64.68 85.75 69.67 77.23 80.75 85.02 79.41 90.19 108.25 138.94 112.06
Operating Profit 53.66 67.24 85.60 61.11 60.49 84.24 116.01 65.58 38.55 61.75 72.06 93.29
OPM % 15.1% 18% 20.6% 15.5% 16% 17.9% 21.9% 17.5% 9.2% 14.5% 12.4% 17.5%
Profit Before Tax + 53.66 67.44 91.28 63.23 63.43 96.18 113.50 67.17 41.70 58.58 82.59 96.22
Tax Expense 12.48 19.25 28.26 16.08 15.60 22.66 24.66 15.95 10.77 14.74 20.55 24.92
Tax % 23.3% 28.5% 31% 25.4% 24.6% 23.6% 21.7% 23.7% 25.8% 25.2% 24.9% 25.9%
Profit After Tax 41.18 48.19 63.02 47.14 47.84 73.52 88.85 51.22 30.93 43.84 62.03 71.31
EPS (Basic) 4.61 5.32 6.95 5.20 5.28 8.11 9.80 5.65 3.41 4.84 6.84 7.87

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 1,797.55 1,771.35 1,502.13 1,511.25
YOY Revenue Growth % 1.48% 17.92% -0.6% -
Other Income 15.32 14.49 11.01 1.28
Total Income 1,812.87 1,785.84 1,513.14 1,512.53
Total Expenses + 1,575.84 1,449.50 1,238.62 1,279.17
Cost of Materials Consumed 834.53 803.98 761.57 899.45
Employee Benefit Expense 170.48 152.88 130.33 122.16
Other Expenses 433.02 312.66 273.67 262.83
Operating Profit 221.71 321.85 263.51 232.08
OPM % 12.3% 18.2% 17.5% 15.4%
Profit Before Exceptional 237.03 336.34 274.52 233.36
Exceptional Items -2.79 0.00 0.00 0.00
Profit Before Tax + 234.24 336.34 274.52 233.36
Tax Expense 58.04 78.99 73.87 61.63
Tax % 24.8% 23.5% 26.9% 26.4%
Profit After Tax 176.20 257.35 200.65 171.73
EPS (Basic) 19.44 28.39 22.14 18.95

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 1,934.33 1,510.81 1,162.85 1,004.30
Property, Plant & Equipment 1,335.92 1,028.77 936.47 847.08
Capital Work in Progress 305.21 300.92 78.50 62.23
Non-Current Investments 44.02 41.15 43.83 42.68
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 36.01 30.55 16.86 1.32
Current Assets + 1,393.43 1,212.80 1,134.06 958.97
Inventories 636.21 544.22 582.15 537.68
Trade Receivables 586.55 552.59 448.82 361.61
Cash and Cash Equivalents 5.54 2.84 4.00 13.11
Current Investments 0.00 15.88 17.83 0.00
LIABILITIES & EQUITY
Total Equity 1,982.35 1,843.87 1,621.46 1,438.58
Equity Share Capital 45.33 45.32 45.31 45.31
Other Equity 1,937.02 1,798.55 1,576.15 1,393.27
Non-Current Liabilities 419.53 257.40 119.87 69.38
Current Liabilities 925.88 622.33 555.58 455.31
Total Liabilities 1,345.41 879.74 675.45 524.69

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 256.13 340.01 183.70 228.69
Cash from Investing Activities -424.02 -419.80 -184.40 -115.56
Cash from Financing Activities 170.58 78.63 4.40 -156.52
Net Increase/Decrease in Cash 2.70 -1.16 3.70 -43.39